Tamiflu News - Who is at Risk From Flu This Winter
19th November 2010
For vulnerable patients at risk of Flu, NICE recommends prescribing Tamiflu for treatment. At Risk Groups
  • patients over 65 years old
  • chronic respiratory disease (including asthma and COPD)
  • Chronic heart disease
  • Chronic renal disease
  • Diabetes mellitus
  • Immunosuppressed patients
  • Chronic neurological conditions
  • Chronic liver disease
During the 2009 H1N1A pandemic pregnant women and children under the age of 5 were identified as additional risk groups by the department of health. Tamiflu is an oral NICE recommended antiviral medicine for treating at risk patients with flu symptoms within 48hrs when influenza is circulating in the community defined by Heath Protection Agency, or equivalent influenza surveillance, whether they are vaccinated or not. Buy Tamiflu online from Medical Specialists online pharmacy to protect against influenza today. References: NICE technology appraisal guidance 168, Amantadine, Oseltamivir and Zanamivir for the treatment of influenza.